APA (7th ed.) Citation

Keller, M. D., Hanley, P. J., Chi, Y., Aguayo-Hiraldo, P., Dvorak, C. C., Verneris, M. R., . . . Pulsipher, M. A. (2024). Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): A two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nature Portfolio.

Chicago Style (17th ed.) Citation

Keller, Michael D., et al. Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES): A Two-arm, Open Label Phase II Interventional Trial of Pediatric Patients with Risk Factor Assessment. Nature Portfolio, 2024.

MLA (9th ed.) Citation

Keller, Michael D., et al. Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES): A Two-arm, Open Label Phase II Interventional Trial of Pediatric Patients with Risk Factor Assessment. Nature Portfolio, 2024.